U.S. markets closed

Acutus Medical, Inc. (AFIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8718+0.0018 (+0.21%)
At close: 04:00PM EDT
0.8401 -0.03 (-3.64%)
After hours: 04:08PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close0.8700
Bid0.8400 x 800
Ask0.9240 x 900
Day's Range0.8166 - 0.8800
52 Week Range0.4800 - 9.6600
Avg. Volume3,121,019
Market Cap24.733M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for AFIB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acutus Medical, Inc.
    ITOS: What does Argus have to say about ITOS?ITEOS THERAPEUTICS INC has an Investment Rating of HOLD; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • GlobeNewswire

    BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council

    Top Executives Bring Expertise to Further Fuel Company Growth Tamara Elias, MD Tamara Elias, MD, joins the BrightInsight Advisory Council Scott Huennekens Scott Huennekens Joins the BrightInsight Advisory Council SAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennekens, e

  • GlobeNewswire

    Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CARLSBAD, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted an equity award on September 1, 2022 that was approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to one individual hired by Acutus in August 2022. The equity

  • GlobeNewswire

    Acutus Medical Reports Second Quarter 2022 Financial Results

    CARLSBAD, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2022. Recent Updates: Reported revenue of $4.1 million in the second quarter of 2022, compared to $3.7 million in the first quarter of 2022, and $4.7 million in the same quarter last year.Global mapping procedures volumes inc